MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC — Stella

Recruiting

Back to TNBC, Triple Negative Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Israel

Tel Aviv Sourasky Medical Center, Tel Aviv

Sheba Medical Center, Tel Litwinsky

Key details

Phase

Safety & dosing

Sponsor

Tel-Aviv Sourasky Medical Center

Collaborators

Sheba Medical Center

Enrollment target

~54 participants

Started

November 2025

Primary completion

February 2028

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov